Kimberly-Clark (NASDAQ:KMB – Get Free Report) is expected to issue its Q3 2026 Prepared Remarks results before the market opens on Thursday, November 5th. Analysts expect the company to announce earnings of $1.65 per share and revenue of $4.13 billion for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2026 Prepared Remarks earnings report for the latest details on the call scheduled for Thursday, November 5, 2026 at 6:30 AM ET.
Kimberly-Clark (NASDAQ:KMB – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%. The company had revenue of $4.19 billion for the quarter, compared to the consensus estimate of $4.22 billion. During the same period in the prior year, the firm posted $1.92 earnings per share. The business’s revenue was up .6% on a year-over-year basis. On average, analysts expect Kimberly-Clark to post $6.83 EPS for the current fiscal year and $7.00 EPS for the next fiscal year.
Kimberly-Clark Stock Down 3.5%
Shares of NASDAQ:KMB opened at $104.46 on Wednesday. Kimberly-Clark has a 52-week low of $92.42 and a 52-week high of $116.82. The firm has a fifty day moving average of $102.66 and a 200 day moving average of $103.09. The firm has a market capitalization of $34.74 billion, a PE ratio of 14.53, a price-to-earnings-growth ratio of 5.85 and a beta of 0.25. The company has a debt-to-equity ratio of 3.45, a quick ratio of 0.69 and a current ratio of 0.91.
Key Headlines Impacting Kimberly-Clark
Here are the key news stories impacting Kimberly-Clark this week:
- Positive Sentiment: Kimberly-Clark completed its acquisition of Kenvue, adding a broad consumer-health portfolio that includes 10 billion-dollar brands. The company reiterated expected annual run-rate synergies of $2.1 billion, offering potential for longer-term growth and cost savings. Read More.
- Neutral Sentiment: The acquisition is now closed, shifting investor focus from deal completion to integration, synergy delivery, and the combined company’s financial performance. KMB’s Q3 results are due November 5. Read More.
- Negative Sentiment: The transaction is substantial: its enterprise value was reported at nearly $49 billion. Kimberly-Clark also announced exchange offers involving up to $7 billion of new company notes, raising investor focus on financing and the added debt burden as it integrates Kenvue. Read More. Read More.
- Negative Sentiment: Analyst previews warn that weak consumer spending and rising costs could weigh on Q3 results, although product innovation and efficiency gains may provide some support. That uncertainty may limit enthusiasm ahead of the earnings report. Read More.
Wall Street Analyst Weigh In
KMB has been the topic of a number of research reports. Piper Sandler lowered their price target on Kimberly-Clark from $121.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, September 11th. Freedom Capital raised Kimberly-Clark from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 4th. UBS Group boosted their target price on Kimberly-Clark from $106.00 to $113.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 28th. Zacks Research lowered Kimberly-Clark from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 20th. Finally, DA Davidson upped their target price on Kimberly-Clark from $106.00 to $116.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $110.67.
Check Out Our Latest Analysis on Kimberly-Clark
About Kimberly-Clark
Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.
The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.
Read More
- Five stocks we like better than Kimberly-Clark
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
